Showing 1,449 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Gilead Begins Single Pill Hepatitis C Study for 2014 Approval

Editor's pick
Businessweek
29 July 2012
Access to healthcare

United States trade policy undermines access to anti-retroviral medicines

Editor's pick
Oxfam
25 July 2012
New & experimental HIV treatments

Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV

Editor's pick
Merck press release
24 July 2012
Pharmaceutical industry

Thailand Urged To Reject Gilead AIDS Drug Patents

Editor's pick
Pharmalot
23 July 2012
HIV treatment for children & young people

DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination

Editor's pick
DNDi
20 July 2012
HIV treatment for children & young people

ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment

Editor's pick
Viiv Healthcare press release
18 July 2012
PrEP

Gilead Wins US Approval for First HIV Prevention Pill

Editor's pick
Bloomberg BusinessWeek
17 July 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV

Editor's pick
Market Watch (press release)
11 July 2012
Access to healthcare

India Weighs Providing Free Drugs at State-Run Hospitals

Editor's pick
New York Times
6 July 2012
Types of HIV tests

OraSure Rises to Highest Price Since 2005 on HIV Test

Editor's pick
Businessweek
6 July 2012
HIV treatment

Next Front in Worldwide AIDS Battle: Stretching Use of Anti-HIV Drugs

Editor's pick
Newswise (press release)
6 July 2012
Pharmaceutical industry

How Secrecy in Medical Research Harms our Health

Editor's pick
Open Society Foundations
5 July 2012
Pharmaceutical industry

EU Parliament Rejects ACTA; Allowing for Continued Access to Generic Medicines in Developing Countries

Editor's pick
MSF
4 July 2012
Clinical trials

How to Tell When A Drug Company Fibs About Clinical Trial Results

Editor's pick
The Street
4 July 2012
Pharmaceutical industry

Tanzania: Muhas Develops Anti-Retroviral Formula

Editor's pick
AllAfrica
3 July 2012
Access to healthcare

Activists in the EECA demand a tenfold reduction of the price for pegylated interferons

Editor's pick
EATG
2 July 2012
Pharmaceutical industry

HIV generics take over the antivirals market

Editor's pick
GBI Research
2 July 2012
Global health initiatives

Gates Foundation readies a round of tempting biotech investments

Editor's pick
Fierce Biotech
2 July 2012
New & experimental hepatitis C treatment

Medivir announces an interferon-free phase II combination trial of hepatitis C drugs TMC435 and daclatasvir to commence shortly

Editor's pick
Medivir
29 June 2012
New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
Access to healthcare

MEPs to 'finish off' ACTA on 4 July

Editor's pick
EurActiv
22 June 2012
Access to healthcare

If you can’t join ‘em, beat ‘em: new industry effort a jab at patent pool?

Editor's pick
Intellectual Property Watch
22 June 2012
Pharmaceutical industry

Roche did not report US patients’ deaths

Editor's pick
Financial Times
22 June 2012
New & experimental hepatitis C treatment

Idenix hep C drug shows promise in mid-stage study

Editor's pick
Reuters
20 June 2012